Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials

por King, Brett, Maari, Catherine, Lain, Edward, Silverberg, Jonathan I., Issa, Maher, Holzwarth, Katrin, Brinker, Dennis, Cardillo, Tracy, Nunes, Fabio P., Simpson, Eric L.
Publicado 2021

Clinical Tailoring of Baricitinib 2 mg in Atopic Dermatitis: Baseline Body Surface Area and Rapid Onset of Action Identifies Response at Week 16

por Silverberg, Jonathan I., Boguniewicz, Mark, Waibel, Jill, Weisman, Jamie, Strowd, Lindsay, Sun, Luna, Ding, Yuxin, Feely, Meghan, Nunes, Fabio P., Simpson, Eric L.
Publicado 2021

Bevacizumab Treatment for Meningiomas in NF2: A Retrospective Analysis of 15 Patients

por Nunes, Fabio P., Merker, Vanessa L., Jennings, Dominique, Caruso, Paul A., di Tomaso, Emmanuelle, Muzikansky, Alona, Barker, Fred G., Stemmer-Rachamimov, Anat, Plotkin, Scott R.
Publicado 2013

Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinic...

por Silverberg, Jonathan I., Simpson, Eric L., Wollenberg, Andreas, Bissonnette, Robert, Kabashima, Kenji, DeLozier, Amy M., Sun, Luna, Cardillo, Tracy, Nunes, Fabio P., Reich, Kristian
Publicado 2021

Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata

por Wyrwich, Kathleen W., Kitchen, Helen, Knight, Sarah, Aldhouse, Natalie V. J., Macey, Jake, Nunes, Fabio P., Dutronc, Yves, Mesinkovska, Natasha, Ko, Justin M., King, Brett A.
Publicado 2020

“‘You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden...

por Aldhouse, Natalie V. J., Kitchen, Helen, Knight, Sarah, Macey, Jake, Nunes, Fabio P., Dutronc, Yves, Mesinkovska, Natasha, Ko, Justin M., King, Brett A., Wyrwich, Kathleen W.
Publicado 2020

Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermati...

por Silverberg, Jonathan I., DeLozier, Amy, Sun, Luna, Thyssen, Jacob P., Kim, Brian, Yosipovitch, Gil, Nunes, Fabio P., Gugiu, P. Cristian, Doll, Helen A., Eichenfield, Lawrence F.
Publicado 2021

The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA‐AD™): a clinical outcome measure for the severity of atopic dermatitis

por Simpson, Eric L., Bissonnette, Robert, Paller, Amy S., King, Brett, Silverberg, Jonathan I., Reich, Kristian, Thyssen, Jacob P., Doll, Helen, Sun, Luna, DeLozier, Amy M., Nunes, Fabio P., Eichenfield, Lawrence F.
Publicado 2022

Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial

por Reich, Kristian, Kabashima, Kenji, Peris, Ketty, Silverberg, Jonathan I., Eichenfield, Lawrence F., Bieber, Thomas, Kaszuba, Aleksandra, Kolodsick, Jill, Yang, Fan E., Gamalo, Margaret, Brinker, Dennis R., DeLozier, Amy M., Janes, Jonathan M., Nunes, Fabio P., Thyssen, Jacob P., Simpson, Eric L.
Publicado 2020

JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial

por Tuttle, Katherine R, Brosius, Frank C, Adler, Sharon G, Kretzler, Matthias, Mehta, Ravindra L, Tumlin, James A, Tanaka, Yoshiya, Haneda, Masakazu, Liu, Jiajun, Silk, Maria E, Cardillo, Tracy E, Duffin, Kevin L, Haas, Joseph V, Macias, William L, Nunes, Fabio P, Janes, Jonathan M
Publicado 2018